CA2425820C - Apport de vecteurs viraux adeno-associes (aav) ameliore par convection - Google Patents

Apport de vecteurs viraux adeno-associes (aav) ameliore par convection Download PDF

Info

Publication number
CA2425820C
CA2425820C CA2425820A CA2425820A CA2425820C CA 2425820 C CA2425820 C CA 2425820C CA 2425820 A CA2425820 A CA 2425820A CA 2425820 A CA2425820 A CA 2425820A CA 2425820 C CA2425820 C CA 2425820C
Authority
CA
Canada
Prior art keywords
aav
cells
aadc
vector
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2425820A
Other languages
English (en)
Other versions
CA2425820A1 (fr
Inventor
Krys Bankiewicz
Janet Cunningham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Genzyme Corp
Original Assignee
University of California
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, Genzyme Corp filed Critical University of California
Priority claimed from CA002329259A external-priority patent/CA2329259C/fr
Publication of CA2425820A1 publication Critical patent/CA2425820A1/fr
Application granted granted Critical
Publication of CA2425820C publication Critical patent/CA2425820C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2425820A 1998-05-27 1999-05-26 Apport de vecteurs viraux adeno-associes (aav) ameliore par convection Expired - Lifetime CA2425820C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8694998P 1998-05-27 1998-05-27
US60/086,949 1998-05-27
US13474899P 1999-05-18 1999-05-18
US60/134,748 1999-05-18
CA002329259A CA2329259C (fr) 1998-05-27 1999-05-26 Apport ameliore par la convection de vecteurs viraux adeno-associes (aav)

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002329259A Division CA2329259C (fr) 1998-05-27 1999-05-26 Apport ameliore par la convection de vecteurs viraux adeno-associes (aav)

Publications (2)

Publication Number Publication Date
CA2425820A1 CA2425820A1 (fr) 1999-12-02
CA2425820C true CA2425820C (fr) 2010-07-20

Family

ID=27171430

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2425820A Expired - Lifetime CA2425820C (fr) 1998-05-27 1999-05-26 Apport de vecteurs viraux adeno-associes (aav) ameliore par convection

Country Status (1)

Country Link
CA (1) CA2425820C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114107231B (zh) * 2021-12-13 2023-08-18 重庆大学 实现全脑突触后神经元胞体标记的重组腺相关病毒及其应用

Also Published As

Publication number Publication date
CA2425820A1 (fr) 1999-12-02

Similar Documents

Publication Publication Date Title
US20180243249A1 (en) Methods of treating parkinson's disease using viral vectors
CA2409674C (fr) Systemes de delivrance bases sur l'acide glutamique decarboxylase (gad)
US20220347319A1 (en) Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders
CA2457057C (fr) Compositions et procedes destines au traitement des maladies neurodegeneratives
ES2745470T3 (es) Partícula de AAV2 que comprende una proteína de la cápside de AAV2 y un vector que comprende un ácido nucleico que codifica una tripeptidilo peptidasa 1 (TPP1) para el tratamiento de lipofuscinosis ceroide infantil tardía (LINCL) en un mamífero no roedor mediante inyección intraventricular o administración icv
AU2002326163A1 (en) Compositions and methods for treating neurodegenerative diseases
US20060073119A1 (en) Methods for treating neurodegenerative disorders
EP1621626B1 (fr) Vecteurs AAV pour la fabrication des médicaments pour l'administration amélioré par la convection
US7695959B2 (en) Glutamic acid decarboxylase (GAD) based delivery systems
CA2425820C (fr) Apport de vecteurs viraux adeno-associes (aav) ameliore par convection

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20190527